NCT00383227View on ClinicalTrials.gov

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

PHASE3CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

November 30, 2000

Study Completion Date

November 30, 2000

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Hepatitis B adjuvanted vaccine

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00383227 - Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years | Biotech Hunter | Biotech Hunter